Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.12%573.28B | 7.24%2.25T | 8.10%550.59B | 8.17%2.1T | 10.03%527.7B | 8.57%519.78B | 6.64%538.27B | 7.52%509.33B | 5.76%1.94T | 4.08%479.58B |
| Cost of revenue | 4.67%391.26B | 6.83%1.53T | 6.47%373.81B | 7.17%1.43T | 8.74%358.5B | 7.98%357.07B | 5.45%365.5B | 6.58%351.11B | 3.77%1.34T | 3.76%329.68B |
| Gross profit | 2.96%182.02B | 8.12%716.73B | 11.73%176.78B | 10.41%662.9B | 12.87%169.2B | 9.89%162.71B | 9.25%172.77B | 9.67%158.22B | 10.49%600.39B | 4.78%149.9B |
| Operating expense | 3.65%140.67B | 6.07%554.44B | 8.29%135.72B | 5.57%522.71B | 10.22%139.28B | 3.34%127.94B | 4.49%130.15B | 4.09%125.34B | 8.89%495.13B | 7.57%126.36B |
| Operating profit | 0.70%41.35B | 15.77%162.3B | 24.86%41.06B | 33.19%140.19B | 27.09%29.92B | 43.33%34.77B | 26.89%42.62B | 37.77%32.89B | 18.69%105.26B | -8.05%23.55B |
| Net non-operating interest income (expenses) | 41.84%-645M | 14.28%-5.08B | 27.04%-1.11B | 13.02%-5.92B | 26.16%-1.31B | 13.83%-1.46B | 5.60%-1.64B | 5.71%-1.52B | -2.34%-6.81B | 4.78%-1.77B |
| Non-operating interest income | 86.18%916M | 24.74%1.33B | 4.02%492M | 19.04%1.06B | 15.45%254M | -22.83%142M | 30.20%194M | 39.12%473M | 4.44%893M | 56.03%220M |
| Non-operating interest expense | -2.50%1.56B | -8.35%6.4B | -19.67%1.6B | -9.31%6.99B | -21.56%1.56B | -14.71%1.6B | -2.76%1.83B | 2.10%1.99B | 2.58%7.7B | -0.50%1.99B |
| Net investment income | 106.91%682M | -144.94%-4.62B | -423.25%-9.87B | 60.09%10.28B | -7.37%5.93B | 1,078.29%5.95B | 6.32%-4.66B | -45.41%3.05B | -58.49%6.42B | -22.45%6.4B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -20.80%198M | -7.66%615M | 2.88%250M | -1.91%666M | -9.95%190M | -41.08%109M | -6.77%124M | 62.00%243M | 36.35%679M | 90.09%211M |
| Special income (charges) | -107.95%-59M | -18.84%-21.63B | 347.33%742M | -77.51%-18.2B | -71.32%-14.78B | -467.44%-2.7B | 55.19%-423M | -44.23%-300M | -21.96%-10.25B | -14.49%-8.63B |
| Less:Restructuring and mergern&acquisition | ---362M | ---798M | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 1,459.26%421M | -1.86%3.96B | -91.00%27M | -5.48%4.04B | -76.81%613M | 467.44%2.7B | -55.19%423M | 44.23%300M | 58.48%4.27B | 45.70%2.64B |
| Less:Write off | ---- | 30.37%18.47B | ---769M | 136.75%14.17B | ---- | ---- | ---- | ---- | 4.60%5.98B | ---- |
| Other non-operating income (expenses) | -66.05%605M | 52.39%5.33B | 27.38%1.78B | -35.82%3.5B | -79.72%388M | -53.88%612M | -27.99%1.1B | 104.53%1.4B | 123.75%5.45B | 207.06%1.91B |
| Income before tax | 28.24%42.13B | 4.91%136.91B | -8.14%32.85B | 29.55%130.51B | -6.14%20.34B | 62.13%37.28B | 34.51%37.12B | 25.59%35.76B | 9.47%100.74B | -14.01%21.67B |
| Income tax | 14.64%13.26B | 5.19%45.56B | 5.49%11.57B | 23.86%43.31B | -32.56%5.29B | 62.63%13.55B | 45.36%13.5B | 15.40%10.97B | 15.48%34.97B | -21.47%7.84B |
| Net income | 35.63%28.87B | 4.77%91.35B | -14.16%21.29B | 32.57%87.2B | 8.86%15.05B | 61.84%23.73B | 29.00%23.62B | 30.70%24.8B | 6.52%65.77B | -9.11%13.83B |
| Net income continuous operations | 35.63%28.87B | 4.77%91.35B | -14.16%21.29B | 32.57%87.2B | 8.85%15.05B | 61.85%23.73B | 29.01%23.62B | 30.69%24.8B | 6.52%65.77B | -9.11%13.83B |
| Noncontrolling interests | -52.26%391M | 155.85%840M | 333.33%819M | -279.80%-1.5B | -84.24%-1.57B | -176.47%-141M | 170.00%14M | -64.00%189M | -117.58%-396M | -16.44%-850M |
| Net income attributable to the company | 39.14%28.48B | 2.04%90.51B | -16.84%20.47B | 34.06%88.7B | 13.23%16.62B | 62.23%23.87B | 28.79%23.61B | 33.39%24.61B | 6.85%66.17B | -7.94%14.68B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 39.14%28.48B | 2.04%90.51B | -16.84%20.47B | 34.06%88.7B | 13.23%16.62B | 62.23%23.87B | 28.79%23.61B | 33.39%24.61B | 6.85%66.17B | -7.94%14.68B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 39.00%9.53 | 1.98%30.318 | -16.90%6.856 | 33.98%29.728 | 13.12%5.568 | 62.21%8 | 28.70%7.91 | 33.32%8.25 | 8.09%22.188 | -7.90%4.922 |
| Diluted earnings per share | 38.99%9.49 | 1.93%30.19 | -16.99%6.828 | 33.81%29.618 | 12.87%5.542 | 61.91%7.966 | 28.57%7.884 | 33.28%8.226 | 8.07%22.134 | -7.95%4.91 |
| Dividend per share | 0 | 66.67%7 | 0 | 5.00%4.2 | 0.00%3.2 | 0 | 25.00%1 | 0 | 17.65%4 | 14.29%3.2 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |